Interventions: The intervention comprises of single time-point pharmacogenetics screening for: 1. DPYD gene test for patients newly commencing on 5-fluorouracil and capecitabine chemotherapy 2. UGT1
Supplementary Table 7 shows the top combination-cancer type pairs in hematological cancers showing activity in at least 10% of tested cell lines in that specific cancer type ranked based on their acti